Online citations, reference lists, and bibliographies.
← Back to Search

Polyelectrolyte-coated Nanocapsules Containing Cyclosporine A Protect Neuronal-like Cells Against Oxidative Stress-induced Cell Damage

M. Piotrowski, D. Jantas, M. Leśkiewicz, K. Szczepanowicz, P. Warszyński, W. Lasoń
Published 2018 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Experimental data have demonstrated the neuroprotective potential of cyclosporine A (CsA), however, its clinical usage as neuroprotectant is limited due to poor blood-brain barrier permeability and potential peripheral and central toxicity. In order to overcome these limitations, the nanoparticulate CsA delivery technology has been recently proposed to improve CsA immunosuppressive potential, however, its neuroprotective action has not been sufficiently studied. Thus, in the present study two types of (bio)polyelectrolyte-coated nanocapsules containing CsA (AOT/PLL-CsA and AOT/PLL/PGA-CsA) were synthesized using a nanoemulsification technique and the layer-by-layer (LbL) saturation method. By using human neuroblastoma SH-SY5Y cells, we demonstrated that CsA alone at a concentration above 0.1 μM had a cell-damaging effect. CsA at lower concentrations (0.1–10 nM) was devoid of toxicity and reduced the hydrogen peroxide (H2O2)-induced cell damage, whereas its higher contents (0.5 and 1 μM) increased oxidative stress-induced cell death. Further studies showed that both forms of nanoencapsulated CsA were biocompatible and protected SH-SY5Y cells against the H2O2-induced damage in the range of concentrations 0.04–0.16 μM, therefore, the proposed nanoformulations for CsA delivery are suitable to reduce its cytotoxic effects and enhance the neuroprotective activity against oxidative stress.
This paper references
10.1016/j.neuint.2014.12.007
SK channel activation modulates mitochondrial respiration and attenuates neuronal HT-22 cell damage induced by H2O2
M. Richter (2015)
10.1007/s00702-015-1398-0
Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection
Yuqiu Wu (2015)
10.1155/2012/428010
Mechanism of Oxidative Stress in Neurodegeneration
S. Gandhi (2012)
10.1016/j.neuint.2014.12.011
Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation
D. Jantas (2015)
10.2174/157015909787602823
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Bayani Uttara (2009)
10.1016/j.neuroscience.2007.11.032
Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide–induced oxidative stress condition
V. Schaeffer (2008)
10.1691/PH.2014.2206
Cytotoxicity and anti-inflammatory activity of cyclosporine A loaded PLGA nanoparticles for ocular use.
K. Hermans (2014)
10.1007/s00709-015-0930-2
Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease
M. Z. Rasheed (2015)
10.3390/ijms141224438
Oxidative Stress and Neurodegenerative Disorders
J. Li (2013)
10.1155/2017/2525967
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Zewen Liu (2017)
10.1002/jcb.22521
Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid‐differentiated SH‐SY5Y cells
S. Wenker (2010)
10.1016/j.ijpharm.2016.01.037
Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies.
M. Guada (2016)
10.1007/BF03033178
Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists
Steven P. Presgraves (2009)
10.1016/j.neuropharm.2014.03.019
Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state
D. Jantas (2014)
10.1016/j.npep.2011.04.002
Cyclosporine-A as a neuroprotective agent against stroke: Its translation from laboratory research to clinical application
M. Osman (2011)
10.1016/j.brainres.2010.03.102
Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies
F. M. Lopes (2010)
10.1155/2014/683153
Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh (2014)
10.1096/fj.10-154690
Polylactide‐cyclosporin A nanoparticles for targeted immunosuppression
J. Azzi (2010)
10.1016/j.jconrel.2011.01.010
Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
P. Aksungur (2011)
10.1155/2012/896141
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
L. Tang (2012)
10.5607/en.2015.24.4.325
The Role of Oxidative Stress in Neurodegenerative Diseases
G. Kim (2015)
10.1016/j.neuro.2008.11.001
Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Yuen-Ting Cheung (2009)
10.1016/S0005-2728(98)00177-7
Visualization of cyclosporin A and Ca2+-sensitive cyclical mitochondrial depolarizations in cell culture.
C. P. Fall (1999)
10.1016/j.tiv.2015.01.003
Cyclosporine A kinetics in brain cell cultures and its potential of crossing the blood-brain barrier.
P. Bellwon (2015)
10.1002/JPS.2600820513
Formation and characterization of cyclosporine-loaded nanoparticles.
M. Guzmán (1993)
10.1111/j.1471-4159.2006.03914.x
The radical scavenger CR‐6 protects SH‐SY5Y neuroblastoma cells from oxidative stress‐induced apoptosis: effect on survival pathways
N. Sanvicens (2006)
10.1002/1873-3468.12894
mPOS is a novel mitochondrial trigger of cell death – implications for neurodegeneration
Liam P Coyne (2018)
10.1016/j.neuroscience.2013.12.067
Gamma-hydroxybutyrate, acting through an anti-apoptotic mechanism, protects native and amyloid-precursor-protein-transfected neuroblastoma cells against oxidative stress-induced death
G. Wendt (2014)
10.1002/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U
Cyclosporin A protects striatal neurons in vitro and in vivo from 3‐nitropropionic acid toxicity
L. Leventhal (2000)
10.1046/j.1471-4159.2002.01047.x
Mitochondrial permeability transition mediates apoptosis induced by N‐methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, N‐propargyl‐1(R)‐aminoindan
Y. Akao (2002)
10.2174/1871527316666170424114444
Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer's Disease.
E. Shevtsova (2017)
10.1080/1061186X.2016.1191082
New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes
Shi-jie Gao (2017)
10.1016/S0014-2999(00)00584-7
Cyclosporin A targets involved in protection against glutamate excitotoxicity.
F. Ruiz (2000)
10.1038/srep20467
Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening
Gentaro Ikeda (2016)
10.1088/0957-4484/27/35/355101
Encapsulation of curcumin in polyelectrolyte nanocapsules and their neuroprotective activity.
K. Szczepanowicz (2016)
10.1290/1071-2690(2000)036<0081:RSOUAC>2.0.CO;2
Relative sensitivity of undifferentiated and cyclic adenosine 3′, 5′-monophosphate-induced differentiated neuroblastoma cells to cyclosporin A: potential role of β-amyloid and ubiquitin in neurotoxicity
A. Kumar (2000)
10.5487/TR.2010.26.3.163
Use of Antioxidants to Prevent Cyclosporine A Toxicity
Jinhwa Lee (2010)
10.1016/j.phrs.2015.05.007
Mitochondrial Ca(2+) in neurodegenerative disorders.
R. Abeti (2015)
10.1016/j.ejpb.2017.03.006
Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts
F. Lallemand (2017)
10.1159/000446850
Cyclosporine A, a Potential Therapy of Ischemic Reperfusion Injury. A Common History for Heart and Brain
N. Nighoghossian (2016)
10.1007/s11051-013-2035-1
Emulsion-core and polyelectrolyte-shell nanocapsules: biocompatibility and neuroprotection against SH-SY5Y cells
M. Piotrowski (2013)
10.1016/j.ejmech.2016.12.057
Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction.
Ahmed Elkamhawy (2017)
10.1016/J.JCONREL.2004.01.017
Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process.
J. Jaiswal (2004)
10.1016/j.colsurfb.2015.07.029
Polyelectrolyte-coated nanocapsules containing undecylenic acid: Synthesis, biocompatibility and neuroprotective properties.
M. Piotrowski (2015)
10.1002/jcb.25236
An Involvement of PI3‐K/Akt Activation and Inhibition of AIF Translocation in Neuroprotective Effects of Undecylenic Acid (UDA) Against Pro‐Apoptotic Factors‐Induced Cell Death in Human Neuroblastoma SH‐SY5Y Cells
D. Jantas (2015)
10.1016/J.MOLBRAINRES.2003.11.006
Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm.
K. Domanska-Janik (2004)
10.1016/j.ejpn.2015.02.003
Age-dependent vulnerability of cyclosporine-associated encephalopathy in children.
L. Chen (2015)
Neurotoxicity of immunosuppressive therapies in organ transplantation.
D. Anghel (2013)
10.1111/cns.12546
Cyclosporine A Treatment Abrogates Ischemia‐Induced Neuronal Cell Death by Preserving Mitochondrial Integrity through Upregulation of the Parkinson's Disease‐Associated Protein DJ‐1
N. Tajiri (2016)
10.1016/j.ejpb.2012.05.003
Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles.
K. Hermans (2012)
10.1016/j.neuint.2007.10.003
The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells
D. Jantas (2008)
10.1007/s11064-013-0968-5
Oxygen Glucose Deprivation (OGD)/Re-Oxygenation-Induced In Vitro Neuronal Cell Death Involves Mitochondrial Cyclophilin-D/P53 Signaling Axis
Liping Zhao (2013)
10.1016/j.tiv.2015.05.016
Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models.
L. Schultz (2015)
10.1016/J.JCONREL.2007.02.004
PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
J. L. Italia (2007)
10.1016/j.brainres.2007.02.036
Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models
Y. Muramatsu (2007)
10.1016/j.bbrc.2016.12.068
The cyclophilin D/Drp1 axis regulates mitochondrial fission contributing to oxidative stress-induced mitochondrial dysfunctions in SH-SY5Y cells.
Anqi Xiao (2017)
10.1016/j.jns.2017.02.043
Mitochondrial dysfunction – Silent killer in cerebral ischemia
Pramila Bakthavachalam (2017)
10.1179/1743132813Y.0000000202
Diazoxide and cyclosporin A protect primary cholinergic neurons against beta-amyloid (1-42)-induced cytotoxicity
Xianwei Zeng (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar